NCT01812369View on ClinicalTrials.gov

Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 25, 2023

Study Completion Date

September 25, 2023

Conditions
Bladder Cancer
Interventions
DRUG

GEMCITABINE CISPLATINE

DRUG

METHOTRXATE VINBLASTINE DOXORUBICINE CISPLATINE G-CSF

Trial Locations (1)

76031

UHRouen, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT01812369 - Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter